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INTRODUCTION AND REVIEW OF THE LITERATURE
Sensitivity of the Auditory System
The mammalian cochlea is both a structurally and functionally complex organ, so
it’s not surprising that only a portion of the physiologic mechanisms that act to enhance
auditory system sensitivity have been discovered. Much is known about the mechanical
amplification processes that are essential for enhanced sensitivity and sharp frequency
selectivity. Less information is available pertaining to the actual event of signal
transduction between the hair cell and the cochleovestibular nerve that carries the
auditory signal to the brain.
We know that the external ear aids in sound localization and increases sound
pressure levels through resonance. There are several mechanisms in the middle ear that
are known to enhance auditory sensitivity. As an impedance matching device, the middle
ear functions to increase force and pressure (energy) in the transmission of sound waves.
The tensor tympani and stapedius muscles act to stiffen the ossicular chair, which
augments the perception of higher frequency sounds. This action fights the upward
spread of masking phenomenon. The acoustic reflex in the middle ear, which functions
as a natural amplitude compressor, is known to aid in speech discrimination above 90 dB.
The cochlear amplifier is a functional process controlled by outer hair cell
motility. It reflects how outer hair cells actively respond to acoustic stimulation and
contribute to physiologic auditory enhancement. Through appropriately timed
electromechanical feedback, outer hair cells are believed to amplify and sharpen
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frequency tuning (Russell et al., 2003). Hearing becomes degraded when the outer hair
cells are damaged.
As sound travels up the auditory pathway, the medial superior olive and the lateral
superior olive use timing and intensity, respectively, to enhance differences in
stimulation. Detection of interaural intensity differences and the preservation and
transmission of timing information in the auditory brainstem nuclei is crucial for sound
localization (Saul et al., 2008). The expression of voltage-gated potassium channels
facilitates prompt responses to stimuli, which improves neural synchronization (Joris et
al., 1994). As sound descends along the auditory pathway, the olivocochlear bundle
functions to improve signal detection in noise, as well as protect the cochlea from
mechanical damage and over stimulation.
There are several neural codes that allow a finely tuned auditory system. The
place code suggests that the activity of a neuron is correlated to the location of the hair
cell to which it is connected. Auditory nerve fibers are narrowly tuned to provide highly
specific frequency information. The temporal code emphasizes that stimulus information
is relayed by the rate of neuronal discharges. This release, or action potential, is the
required neuronal response for signal transmission. Neurons are thought to be
functionally organized by phase locking and firing to specific parts of a cyclic stimulus.
When the phase locking abilities of a group of neurons is summed, stimulus frequencies
can be more completely described. The maintenance of high-frequency timing
information is crucial for decoding complex sounds, such as speech recognition (Oertel,
1999).
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Normal auditory processing is necessary for complex listening, learning, and
communication. As discussed earlier, the central auditory nervous system allows for
sound localization using temporal and amplitude cues, as well as pitch and tone judgment
(Katz, 2002). An auditory processing disorder (APD) occurs when there is a deficiency
in one or more of the following: sound localization, temporal aspects of audition,
auditory performance with competing acoustic signals, and auditory performance with
degraded acoustic signals (ASHA, 1996). Individuals with auditory processing disorders
have trouble interpreting acoustic input.
Glutamate, stored in pre-synaptic vesicles, is the primary excitatory
neurotransmitter of the auditory system. Metabolism, vesicular transport, synaptic reuptake and its effect on post-synaptic receptors can all play roles in glutamate toxicity
(Tadros et al., 2007). Changes of glutamate, serotonin, and gamma amino butyric acid
(GABA) have been associated with age and/or hearing loss in the mouse inferior
colliculus (Tadros et al., 2007). It has been proposed that gene-regulated modifications
of these neurotransmitter receptors are linked to age-related changes in complex sound
processing. The dysfunction and changed regulation of the excitatory/inhibitory
neurotransmitter pathways are considered key roles in the complex sound processing
deficits associated with age related hearing loss, or presbycusis (Christensen et al., 2009).
The auditory cortex is the site of significant functional changes in genetic
expression correlated with presbycusis. This disorder occurs due to an accumulation of
auditory stressors superimposed on a genetically regulated aging process. Presbycusis
begins with reduced sensitivity at high frequencies. Auditory processing abilities decay
and sound localization becomes impaired. Different types of presbycusis involve a loss
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of outer hair cells, the degeneration of stria vascularis, a reduction of spiral ganglion cells
and/or reduction in synaptic activity in the central auditory pathway. Noise exposure is
the number one risk factor for presbycusis.

Noise Induced Hearing Loss
According to the National Institute for Occupational Safety and Health (2001),
permanent noise-induced hearing loss (NIHL) is the chief health hazard posed by
occupational and recreational situations. Of the 30 million cases of hearing loss in the
United States, one third are related to noise exposure. NIHL involves the irreparable
loss of afferent neurons and cochlear hair cells which leads to auditory threshold
deterioration (reviews: Slepecky, 1986 and Saunders et al., 1991). NIHL
characteristically involves high frequencies (3-8 kHz).
The mechanisms of NIHL are similar to the types of presbycusis described earlier.
Intense noise can cause spiral ganglion cell and hair cell (outer more than inner)
degeneration and loss (Clark and Bohne, 1999). Excitotoxicity mechanisms lead to
metabolic exhaustion and neuronal damage. Physical trauma can cause injury to the
tectorial membrane, basilar membrane, and stereocilia. Noise can act as a mechanical
stressor by overstretching inner ear tissues. The tectorial membrane may no longer be
properly anchored to create the shearing force necessary for stereocilia deflection, and the
organ of Corti may separate from the basilar membrane. If noise is too intense, it can
also lead to vascular constriction, which reduces blood flow in the stria vascularis.
Whether noise is harmful depends on its intensity, frequency, duration, and
individual susceptibility. In the case of this study, a temporary threshold shift (TTS)
classifies transient hair cell dysfunction 24-48 hours after exposure and is not a stable
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auditory threshold loss. A permanent threshold shift (PTS) is irreversible and the hearing
loss is considered stable 14 days post noise exposure. Recent studies have explored
cellular occurrences that can lead to sensory cell loss, including calcium dysregulation
(Le Prell et al., 2006) and oxidative stress (Evans and Halliwell, 1999).

Synuclein Proteins
From the preceding discussion, synuclein proteins might be of interest for hearing
because of their function in synaptic regulation and vesicle transport. Synucleins are
therefore likely involved in the synaptic activity of the auditory system. Synucleins are
small, soluble, proteins that are principally expressed in neurons and some varieties of
cancer. This lipid membrane binding family consists of at least three isoforms: alpha,
beta, and gamma synuclein. Over the past two decades, synuclein research has been
resplendent with intriguing hypotheses, stimulating conclusions, and controversial
information (Surguchov, 2008).
Maroteaux and colleagues (1988) coined the term “synuclein” after finding these
proteins in both neural nuclear envelopes and pre-synaptic terminals. Alpha synuclein
was initially isolated from cholinergic vesicle preparations of the electric organ of the ray
Torpedo californica (Surguchov, 2008). Alpha synuclein was then recognized as a
protein involved in synaptic plasticity in song learning in the zebra finch (George et al.,
1995). Several years later a second member of the synuclein family, Beta synuclein, was
discovered in the bovine brain. Gamma synuclein, the most recent isoform identified in
mammalian species, was identified independently in several laboratories and termed
breast cancer specific gene 1 (Surguchov, 2008).
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Synuclein Localization
Alpha, beta, and gamma synucleins are localized in various areas within the
peripheral and central nervous systems. Alpha and beta synuclein are primarily found at
pre-synaptic nerve terminals in the central nervous system. Alpha and beta synuclein,
abundantly expressed and developmentally regulated in the central nervous system, are
upregulated by growth factors (Surguchov, 2008). In contrast, gamma synuclein is
predominantly localized in the peripheral nervous system and has a different pattern of
expression and regulation.
In 1992, Mori and colleagues localized alpha, beta, and gamma synucleins
through immunohistochemistry. Alpha and beta are located in the name neurons, but in
separate subregions. Alpha synuclein is primarily associated with synaptic terminals,
while beta synuclein is found more extensively in the cell body. Alpha synuclein is found
in areas of the brain where continual synaptic changes occur, such as the olfactory bulb,
deeper layers of the cerebral cortex, and pontine nucleus (Clayton & George, 1998). It is
most concentrated in the caudate nucleus, substantia nigra, putamen and ventral pallidus,
basal ganglion, and catecholaminergic regions in the midbrain (Li et al., 2002). Beta
synuclein has been discovered more widely and uniformly in the central nervous system,
including the granular cell layer of the olfactory bulb, layer IV of the cerebral cortex,
CA3 of the hippocampus, basal ganglia, and thalamic reticular nuclei. Gamma synuclein
resides mainly in neuronal cytosol of the peripheral nervous system and epidermis, as
well as the central nervous system (Norris et al., 2004). This protein is found in both
cholinergic and catecholaminergic regions of the midbrain. Gamma synuclein is most
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concentrated at the locus coerueus in the brainstem and the nuclei of most cranial nerves
(Li et al., 2002).

Suggested Physiologic Roles
The functional roles of synuclein proteins are often assumed by their location.
Little is definitively understood about the cellular roles of synuclein proteins. Alpha
synuclein is speculated to play a role in vesicle transportation, maintenance of synaptic
vesicle pools, and signal-induced cytoskeletal regulation. Beta synuclein plays a
proposed role in vesicular transport and sperm cell meiosis.
Information pertaining to synuclein function mainly stems from what is known
about alpha synuclein proteins. The flexibility in alpha synuclein formation is based on
an influential environment, due to its amino acid structural patterns (Sidhu et al., 2004).
At a physiological level, alpha synuclein can function in vesicle synthesis and synaptic
neurotransmitter release. When alpha synuclein is over expressed, it can also result in
inappropriate deployment of these functions at the synapse (Surguchov, 2008).
Alpha synuclein proteins have several proposed functions. One proposed function
is that of a regenerator. Quilty et al. (2003) reported that both alpha and beta synuclein
gather around damaged neuronal terminals. Fan et al. (2006) reported that an increased
expression of beta synuclein yields reduced alpha synuclein expression. Alpha and beta
synuclein proteins seem to be inversely regulated. Beta synuclein proteins may help to
balance alpha synucleins and block them from accumulating (Adamczyk, Solecka &
Strosznajder, 2005). Alpha synuclein is also thought to play a role in the regeneration of
epithelial basal cells and receptor neurons in the olfactory system (Duda et al., 1999).
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Another proposed role of alpha synuclein is that of a synaptic regulator. The
protein sustains synaptic flow by regulating vesicle flow in neuronal pre-synaptic
terminals. In 2002, Cabin et al. found decreased levels of synapsin, a protein that
regulates synaptic neurotransmitter release, in alpha synuclein knockout mice (relative to
wild-type littermates). This discovery suggests that alpha synuclein is necessary for
optimal synaptic maintenance.
In 2004, Sidhu and colleagues reported that the alpha synuclein plays a functional
role in the modulation of dopamine transporter function. This suggests that alpha
synuclein has a responsibility in regulating the synaptic integrity of dopamine.
Interference in alpha-synuclein’s ability to perform this function can produce abnormal
cellular dopamine content. This can result in neurodegeneration of the synaptic nerve
terminals. While alpha synuclein is not a toxic protein, but it can transform into a toxic
molecule with the company of oxidized dopamine (Sidhu et al., 2004).
Alpha synuclein has been shown to function as a normal regulatory protein by
binding to and reducing the activity of tyrosine hydroxylase, a rate-limiting enzyme
involved in dopamine biosynthesis (Perez and Hastings, 2004). High doses of
proteasomal inhibition are known to be toxic. In 2004, Snyder and colleagues reported
that alpha synuclein acts as a molecular chaperone to regulate proteasomal inhibition.
However, Sawada et al. (2004) proposed that low level proteasomal inhibition might be
protective.
A recently hypothesized third role for alpha synuclein is that of a neuroprotector.
A molecular chaperone protects cells by facilitating degradation of injured proteins. In
2001, Chandra and colleagues found that transgenic expression of alpha synuclein
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eradicates the fatality and neurodegeneration caused by deletion of the molecular
chaperone cysteine-string protein-alpha (CSPα). CSPα is another synaptic vesicle protein
that functions to prevent the growth of potentially toxic molecules at nerve terminals.
Mice lacking CSPα without transgenic alpha synuclein develop progressive, eventually
lethal neurodegeneration (Fernandez-Chacon et al., 2004). A loss of endogenous
synuclein action accelerated degeneration of pre-synaptic nerve terminals in these mice
(Chandra et al., 2005). CSPα-deficient mice expressing transgenic alpha synuclein have
a much greater survival rate. Thus, it appears that up regulation of alpha synuclein
compensates for the loss of CSPα activity to suppress pre-synaptic deterioration. In these
mice, alpha synuclein acts by a downstream mechanism entailing phospholipid binding,
which suggests that it operates to protect nerve terminals from injury (Chandra, 2004).
Apoptotic proteins, when associated with alpha synucleins, show reduced
expression and activity. Alpha synuclein acts as a mitochondrial protector by blocking
activity and expression of the Parkinson’s Disease-inducing neurotoxins (Sawada et al.
2004). However, according to Sidhu and colleagues (2004), this protective action might
be dependent upon the level of cell differentiation, or may change with maturation.

Pathologic Roles of Synucleins
Both alpha and beta synuclein are most recognized for their role in protein
aggregations that are the hallmark of Alzheimer’s Disease and Parkinson’s Disease. The
“synucleinopathies” are a collection of neurodegenerative diseases with similar
pathologic lesions and aggregations of synuclein proteins including Parkinson’s disease,
Alzheimer’s disease, Huntington’s disease, and dementia with lewy bodies. Synuclein
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aggregation can directly damage the ubiquitin proteasome system and trigger apoptosis
(Snyder et. al, 2005).
Gamma synucleins typically serve the same functions as alpha and beta, but to a
lesser extent (Quilty et al., 2003). Gamma synuclein is also known as breast cancer
specific gene-1 (BCSG-1) and has several functions. Gamma synuclein stimulates the
ligand-dependent transcriptional action of estrogen receptor-α in cultured breast cancer
cells, stimulates cell proliferation, and up-regulates matrix metalloproteases, which are
enzymes implicated in tumorigenesis and neurodegeneration (Snyder et al., 2004). In
2004, Snyder and colleagues reported an association between gamma synuclein and the
cellular response to oxidative stress.
Gamma synuclein proteins may be uniquely involved in cytoskeletal preservation
(Norris et al., 2004). Gamma synuclein also has the capability to block JNK signaling,
which is commonly correlated with induction of apoptosis (Pan et al., 2002). In 2003,
Ninkina and colleagues reported that gamma synuclein is not crucial for motor and
peripheral sensory neuron function, regardless of high expression levels.
In 1996, Polymeropoulous and colleagues identified a locus for early onset
Parkinson’s disease, an autosomal dominant trait found in a small number of families,
was mapped to the same region of chromosome 4 as the human alpha synuclein gene.
PARK1 is a point mutation in alpha synuclein (A53T) associated with familial
Parkinson’s disease development. Patients with the A53T mutation show signs of
neuronal death, gliosis, and extensive lewy bodies in the brain (Spira et al., 2001).
Parkinson’s disease is a synucleinopathy of unknown etiology that causes a
progressive and debilitating movement disorder. Its hallmark symptoms are all
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suggestive of a loss of dopaminergic neurons and dysfunction in the substantia nigra pars
compacta, where lewy bodies are typically located (Hardy et al., 2006). Wild-type alpha
synuclein, found aggregated in the form of amyloid fibrils, is the most abundantly found
component in these proteinaceous plaques (Sung and Eliezer, 2007).
The key to why alpha synuclein accumulates as protein deposits in
synucleinopathies may lie in defective axonal transport (Surguchov, 2008). In several
neurodegenerative disorders, axonal transport breaks down. Alpha synuclein is
transported along axons from the cell body to synaptic terminals. Flawed alpha synuclein
transport leads to a local over expression of the protein in the perikaryon, since it does
not properly leave the cell body (Surguchov, 2008). An over expression of alpha
synuclein can change its typical cellular localization and affect its folding and/or
association with other proteins. This increase in alpha synuclein’s local concentration
may lead to its accumulation as lewy bodies (Surguchov, 2008).

Role of Synucleins in Sensory Systems
The involvement of synuclein proteins in sensory systems has raised exciting
questions and is there is still much to discover. It has been suggested that synuclein
proteins play fundamental roles the sensory systems, including vision and audition. Most
of the literature describes synuclein location and function in the brain, but very little
information is available pertaining to these sensory systems. Surguchov and colleagues
(2001) reported that synucleins are expressed in the optic nerve and retina. Pathologies
associated with retinal dystrophy, such as macular degeneration, retinitis pigmentosa, and
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glaucoma have a common cellular pathway that eventually leads to photoreceptor death
and visual loss.
In the cochlea, alpha and beta synuclein are expressed in spiral ganglion cells,
primarily in the nuclear region (Surgucheva, 2006). Alpha synuclein is expressed
throughout the entire central nervous system and is most plentiful in catecholaminergic
regions (Akil et al., 2008). Alpha synuclein’s presence in the cochlea was suspected,
since Eybalin (1993) reported the function of cholinergic neuronal signaling in the organ
of Corti. In 2008, Akil and colleagues studied synucleins in the mammalian organ of
Corti and discovered that the proteins are expressed in the efferent synapse of outer hair
cell base (alpha and gamma), spiral ganglion (beta), inner spiral bundle (gamma), and
stria vascularis (alpha and beta). Synucleins must play a role in normal auditory function,
as they are localized to the efferent cholinergic neuronal auditory system.
Adamcyzyk and Strosznajder (2006) reported an association between alpha
synuclein and the voltage-gated calcium flux, a functional component of outer hair cell
efferent signaling. The identification of synucleins at the outer hair cell base and efferent
synapse suggest that these proteins are a part of the long-term, sustained release of
acetylcholine in the efferent auditory system. Akil et al. (2008) proposed that because of
the predominant localization of synucleins in the efferent neuronal system of the inner
ear, the proteins might play a role in susceptibility to noise-induced hearing loss.
In 2002, Gates and colleagues proposed that central auditory speech-processing
deficits might be an early manifestation of Alzheimer’s disease. In addition to the
debilitating symptoms of any neurodegenerative disorder, hearing loss can have a
synergistic effect in leading sufferers to social isolation, withdrawal, and even depression.

15

Mooney
Even with normal audiometric thresholds, individuals with central auditory processing
deficits often have difficulty comprehending speech in unfavorable listening situations.
P300, an electrophysiologic measure of central auditory processing, is sensitive to the
degree of cognitive degeneration in synucleinopathies. Gerschlager and colleagues
(2001) reported that P300 latencies were prolonged in Parkinson’s Disease patients.
Artieda et al. (1992) reported a limitation in the auditory temporal processing ability to
detect very short silent intervals (gap detection) in patients with Parkinson’s Disease.
Perhaps an abundance of alpha synuclein could facilitate this process, as its
neuroprotective role in the auditory system has been hypothesized. However, too much
of this protein could cause aggregated clumps that might add to the impairment. Very
few studies like these are available, which leaves much left to discover about central
auditory processing and neurodegenerative disorders like Parkinson’s Disease.

Present Study
From the foregoing, it might be predicted that disruption of synuclein function or
location might impact both peripheral and central auditory function. In our laboratory,
the functional role of synucleins in audition was recently studied. Synuclein isoforms
were primarily localized in spiral ganglion neurons, hair cells, and the stria vascularis. It
was shown that mice with targeted deletions of the gene that codes for alpha-synuclein
exhibit elevated auditory brainstem response thresholds, suggesting a role for the protein
in normal hearing mechanisms. Mice lacking alpha synuclein exhibit a high frequency
hearing loss, which proves that alpha synuclein is essential for maintaining hearing
sensitivity (unpublished data).
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The neuropathologic basis for auditory processing disorders remains poorly
understood (Saul et al., 2008). Although many mouse models of sensorineural hearing
loss that involve the peripheral auditory system have been described, few studies have
described mutations associated with retrocochlear hearing deficits. The current study
seeks to determine the role that alpha-synuclein plays in noise-induced hearing loss and
central auditory processing. Since alpha synuclein aggregation is stimulated by agents
such as age, environmental toxins, and possibly noise, changes were monitored that
might occur in the accumulation of synuclein proteins with exposure to noise in mice.
Among possible outcomes, we questioned whether additional alpha synuclein might
promote an increase in hearing sensitivity, or in susceptibility to noise induced damage.
If, as suspected, alpha-synuclein facilitates synaptic vesicle release then alpha knockout
mice may be protected from noise exposure and alpha over-expressers would suffer
enhanced damage. Conversely, mice over-expressing alpha-synuclein may also exhibit
improper aggregation of this protein which actually may reduce hearing sensitivity and
thus limit noise-induced changes in hearing thresholds. If susceptibility to NIHL is
reduced, this study may find a therapeutic value of alpha synuclein. If we discover
changes in the localization or depletion of alpha synuclein following noise exposure, this
may imply a compensatory mechanism to produce more alpha synuclein when the protein
is used.

17

Mooney
Electrophysiology: Adaptation and Recovery.
Adaptation is the reduction in a neural response due to previous stimulation.
Recovery from adaptation refers to the process by which the auditory nervous system
returns to a baseline level of function following stimulation. Adaptation and recovery
may be examined with a variety of psychoacoustic paradigms including forward masking,
gap detection, and decrement detection. In psychophysics, changes in threshold due to
prior stimulation are examined as measures of adaptation and recovery. Physiologic
experiments examine the changes in firing rates of single neurons or changes in latency
and amplitude of evoked potentials as quantifications of adaptation and recovery.
The modified gap detection paradigm has been used extensively in understanding
age-related changes in the auditory brainstem. Due to the need for a more sensitive
assessment, gap detection testing was an appropriate supplement to auditory brainstem
response (ABR) measures. Boettcher et al. (1993) reported that older (36-month) gerbils,
compared to young adult (6-8 month) gerbils, showed minimal changes in adaptation and
recovery in the most peripheral wave of the ABR. In contrast, recovery from adaptation
was significantly prolonged in more central waves of the ABR in the older gerbils. These
results occurred in the absence of threshold elevations and were thus considered to be
neural, rather than sensory, changes. Comparable results were reported in elderly human
subjects with normal thresholds by Poth et al. (1999).
Changes in response of older mice have also been examined with the modified
gap paradigm by Walton and colleagues (2006). This study reported that single neuron
responses in the inferior colliculus are abnormal in older mice whereas more peripheral
responses are normal. This data supports the argument that adaptation and recovery may
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be abnormal in some subject groups, independently of peripheral sensitivity, and that
such changes may be compared at different levels of the auditory brainstem to allow the
identification of sites of abnormalities in neural processing.
The present study utilized a modified form of a gap detection paradigm to measure
adaptation and recovery in the ABR. Two identical wide-band noises were presented
within a 150-ms window in order to quantify the latency and amplitudes of the ABR to
the onset of each noise stimulus. The time period between the offset of the first noise of
a pair and the onset of the second noise of a pair was varied to determine recovery from
adaptation. This pattern permits examination of the complete ABR waveform, ranging
from the most peripheral wave (representing the auditory nerve bundle) to more central
waves (including the olivary complex and the lateral lemniscus). This allows for
examination of responses from different levels in the auditory brainstem and
identification of differences in adaptation and recovery between the auditory periphery
and more central regions of the brainstem.
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MATERIALS AND METHODS
Animals
19 mice (8-11 weeks of age) were used in the present study. The M83 mouse has
a gene inserted that codes for an over-expression of human alpha synuclein. There were
seven M83 mice genotyped as homozygous for the α-synuclein-producing gene. Five
M83 mice were genotyped heterozygous for the α-synuclein-producing gene. The control
group was comprised of seven wild-type littermates. All mice used were taken from the
same litters. All groups were roughly evenly balanced by gender. Mice were purchased
directly from The Jackson Laboratory (JAX) or were derived from breeders purchased
from JAX. Animal cages were stored in an approved facility at Washington University,
and were kept on a 12/12-light/dark cycle. Food and water were available on an ad-lib
basis.

Auditory Brainstem Response
The basic procedure involved a hearing assessment by auditory brainstem
response (ABR) thresholds on M83 homozygous, heterozygous, and wild type mice.
Threshold sensitivity was evaluated by ABR prior to treatment to obtain baseline
thresholds, again 24-48 hours post noise exposure to assess any temporary threshold shift,
and again 14 days post noise exposure to measure any permanent threshold shift.
Tucker-Davis Technologies (TDT) System II hardware and BioSig 33 software
were used. Calibration occurred prior to any recordings. Animals were anesthetized with
a solution of ketamine and xylazine (80/15 mg/kg, i.p.). Subdermal needle electrodes
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were placed in the mid-back (ground), medial to the pinna of the tested ear (active), and
at the vertex (reference). Body temperature and heart rate were monitored throughout
testing using a rectal probe, and body temperature was maintained at 37.5 ± 1.0°C using
an isothermal pad. The right ear of each mouse was stimulated with 5 msec tonebursts
(1000 repetitions, 20/second, 1.0 msec rise time) at frequencies of 5, 10, 20, 28.3, and 40
kHz while the left ear was compressed. The test was then repeated in the left ear of each
mouse while the right was compressed. Filter settings were 100 to 10,000 Hz and
speaker distance was 7 cm. The first wave of the ABR is thought to be generated by
early auditory nerve and cochlear activity and is the most robust wave of the mouse ABR
(Zheng et al., 1999). Therefore, thresholds were observed as the lowest level that the first
negative peak (wave I) could be identified using the following bracketing technique:
increase attenuation 10 dB following a positive response and decrease attenuation 5 dB
following a negative response.
Anesthesia for ABR recording was well-tolerated, as no animals were lost as a
result. All mice used for evaluation had baseline thresholds within normal limits. ABR
thresholds were also conducted on 19 additional mice, but this data was excluded from
statistical analysis due to a between-ear threshold difference of more than fifteen percent
between ears at any one frequency.

Noise Exposure
The three genotypes of mice were exposed one time to fifteen minutes of
broadband noise (8,000-16,000 Hz) at 110 dB SPL. This procedure occurred 48 hours
post baseline ABR. Groups of two animals were placed in a wire cage mounted on a
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pedestal inserted into a B&K 3921 turntable. To ensure a uniform sound field, the cage
was suspended between four Motorola KSN1020 A piezo ceramic speakers at 0, 90, 180,
and 360 degrees azimuth in a single-walled sound-proof booth with foam treatment
(Industrial Acoustics, Bronx, NY). Noise was produced and filtered with General Radio
1310 generators and Krohn-Hite 3550 filters, respectively. The overall noise level was
checked at various points in the cage using a B&K 4135 1/4 inch microphone in
combination with a B&K 2231 sound level meter. The cage was rotated at approximately
0.013 Hz throughout the duration of the exposure in order to achieve as consistent an
exposure as possible. No attempt was made to provide food or water throughout the
exposure.

Gap Detection
The stimuli were two-octave-wide bands of noise centered at 20 kHz with a 12
dB/octave roll off. Each stimulus lasted 50 ms with rise-fall times nominally equal to 0
ms. Although very short rise-fall times are know to result in spectral splatter, the spectral
width of the noise stimuli were considered to compensate for influences of spectral
splatter. The stimuli were designed using with TDT SigGen software and generated with
a TDT RP 2.1 D/A (100 kHz sampling rate). Signals were routed from the D/A to a PA5
digital attenuator, an earphone buffer, and an ES-1 earphone. Monaural presentation
(free-field) to the right ear was used for all experiments. The presentation level was 70
dB SPL, calibrated with an ACO Pacific microphone.
Stimuli were presented in pairs, as shown in Figure 5. Each stimulus window
consisting of two identical noise stimuli, with a silent period (“gap”) of 4-32 ms
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separating the offset of the first stimulus of a pair from the onset of the second stimulus
of a pair. The total duration of each stimulus window was 150 ms regardless of the gap
duration. A silent period of 5 ms began each stimulus window. The ABR was collected
for the entire 150-ms window. Each stimulus window was repeated every 500 ms.
The ABR waveform for the first and second noises were analyzed in terms of
amplitude and latency for waves 1, 1a, 2, 3, 4, and 5. Figure 6B shows ABR waveforms
elicited by a stimulus pair with gap duration of 16 ms. Figure 6A shows an expanded
waveform elicited by the first noise of a pair. The peak latency of each wave is marked;
as are the amplitude measures for waves 1 and 4. Waveform morphology in the mouse is
not standardized in the literature and the waveform labels are limited to this study.
Similarly, there is little information correlating waveform morphology to structure in the
mouse and thus any such correlations in this paper are extrapolated from data on the cat
and gerbil (Melcher et al., 1996).
Wave 1 is presumed to represent activity from the distal section of the auditory
nerve and wave 1A may represent activity of auditory nerve fibers as they leave the
cochlea. The waves tend to have a short inter-peak latency and for the purposes of this
paper are not considered to be elicited by two separate nerve bundles. Based on data
from other species (and not yet proven in the mouse), wave 2 represents activity of
neurons in the cochlear nucleus, wave 3 represents activity in the superior olivary
complex, and wave 4 represents activity of the lateral lemniscus.
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Statistical Analysis
To investigate the possible function of alpha synuclein in noise-induced hearing
loss, comparison of mean values of ABR thresholds and gap detection were conducted
between homozygous, heterozygous, and wild-type M83 mice was performed with
analysis of variance (ANOVA) with Bonferroni correction. A Holm-Sidak multiple
comparisons significance was defined as a p value less than 0.05. This test was used to
identify differences at specific frequencies.
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RESULTS
Baseline auditory thresholds
Figure 1 shows baseline auditory thresholds by genotype. There was no obvious
phenotype—physical or behavioral—observed in the transgenic mice due to over
expression of α-synuclein gene relative to wild type littermates. Two-Way Repeated
Measures ANOVA revealed no significant interaction between genotype and frequency
for baseline ABR thresholds, F =0.403 p=0.916. The Holm-Sidak multiple comparisons
analysis did not reveal a significant effect of genotype at any individual frequency tested.

Temporary threshold shifts
Figure 2 shows temporary auditory threshold shifts by genotype. A Two-Way
Repeated Measures ANOVA revealed no significant interaction between genotype and
frequency for temporary shift ABR thresholds, F =0.0546 p=1.0. The Holm-Sidak
multiple comparisons analysis did not reveal a significant effect of genotype at any
individual frequency tested.

Permanent threshold shifts
Figure 3 shows permanent auditory threshold shifts by genotype. A Two-Way
Repeated Measures ANOVA (one factor repetition) revealed no significant interaction
between genotype and frequency for permanent shift ABR thresholds, F =0.20 p=0.990.
The Holm-Sidak multiple comparisons analysis did not reveal a significant effect of
genotype at any individual frequency tested.
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In completing post mortem histological examinations on the mice tested in the
study, it was found that the general cochlear architecture was sound.

Adaptation and recovery: Effect of genotype on latency
Figure 7 shows mean latency shifts for wild type, heterozygous, and homozygous
animals. Each wave is shown in a separate panel. At a gap duration of 4 ms, the
heterozygous and homozygous groups had smaller latency shifts than the wild type
group, for each wave. For example, for wave 1, the average shift at 4 ms was 0.8 ms for
the wild type group and less than 0.4 ms for the heterozygous and homozygous groups.
For wave 2, the latency shift for the wild type group was 0.83 ms at 4 ms, whereas the
shift was approximately 0.6 ms for the heterozygous and homozygous groups. Overall,
the differences between the wild type group and the two M83 groups ranged from
approximately 0.25 to 0.5 ms across waves for the 4 ms gap duration.
In contrast with results at the 4-ms gap duration, differences between groups were
less consistent for longer gap durations. For waves 1, 1A, and 2, wild type subjects had
larger latency shifts than M83 groups at both 4 and 8 ms, but shifts were similar across all
three groups at 16 and 32 ms gaps. Waves 3-5 did not show consistent trends across
groups at gap durations of 8-32 ms.
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DISCUSSION
The purpose of the current study was to determine the role that alpha-synuclein plays
in noise-induced hearing loss and central auditory processing. It was hypothesized that
over expression of alpha synuclein would lead to an increase in hearing sensitivity or
increased susceptibility to noise induced damage. If, as suspected, alpha-synuclein
facilitates synaptic vesicle release, then alpha over-expressers would suffer enhanced
damage. Our ABR data revealed that alteration of alpha synuclein does not have any
effect on the susceptibility to noise damage. However, our gap detection data implies a
facilitation of synaptic transmission between hair cells and afferent nerve terminal. This
facilitation appears to enhance central auditory function, as suggested by the resetting
speed demonstrated by the detection of the second noise of the gap. This suggests that
the alpha synuclein protein can play an advantageous role in central auditory function.
The mechanisms that control of synaptic events, such as a modulation of alpha synuclein,
may be a way overcoming the deficits seen in central auditory processing disorders.

Limitations of the present study
One shortcoming of this experiment was the small sample size. It is likely that with a
much larger subject population for gap detection testing, an effect may be found for
waves 2 and 3. Also relative to gap detection, it is difficult to maintain exact placement
of the electrodes across mice. This may account for some of the variability between
mice.
The mice used in this study come from a mixed background: B6 and C3H. We chose
this mouse for study because it shares the background of knockout and transgenic models
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we hoped to test to support the present findings. The use of this mouse may have
impacted our results by increasing variability, but the mice were all used prior to the age
where we could see hearing loss in a C57 background.

Clinical Implications and Future Studies
The Gap Detection paradigm provides evidence for a specific role of alpha
synuclein in the central auditory pathway. Alpha synuclein facilitates transmission
between the hair cell and the afferent nerve terminal. The present study documents
support for the use of gap detection as a feasible measure of assessing differences in
hearing sensitivity that are not readily apparent in ABR threshold differences. Mouse gap
detection studies can be used in the future to better elucidate the mechanisms of central
auditory processing. Further research should assess alpha and beta synuclein knockouts
in gap detection testing. These investigations, especially if waves 2 and 3 are assessed,
may provide a more extensive look into the central auditory pathway.
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Figure 1.
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Figure 1: Baseline Auditory Thresholds.
This is a bar graph of the baseline ABR thresholds for M83 heterozygous, M83
homozygous, and their wild-type counterpart mice. On the x-axis is frequency in kHz
and the y-axis is ABR thresholds in dB. The red bar represents the heterozygous mice,
the green bar represents the homozygous mice, and the blue bar represents the wild-type
mice. In this graph, you can see that the baseline auditory thresholds for M83 mice are
not significantly different from the wild-type mice.
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Figure 2.
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Figure 2: Temporary Threshold Shifts.
This is a bar graph of the temporary threshold shifts for M83 homozygous, M83
heterozygous, and their wild-type counterpart mice. On the x-axis is frequency in kHz
and the y-axis is ABR thresholds in dB. The red bar represents the homozygous mice,
the green bar represents the heterozygous mice, and the blue bar represents the wild-type
mice. In this graph, you can see that the temporary threshold shifts for M83 mice are not
significantly different from the wild-type mice.
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Figure 3.
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Figure 3: Permanent Thresholds Shifts.
This is a bar graph of the permanent threshold shifts for M83 homozygous, M83
heterozygous, and their wild-type counterpart mice. On the x-axis is frequency in kHz
and the y-axis is ABR thresholds in dB. The red bar represents the homozygous mice,
the green bar represents the heterozygous mice, and the blue bar represents the wild-type
mice. In this graph, you can see that the permanent threshold shifts for M83 mice are not
significantly different from the wild-type mice.
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Figure 4.
Mean Threshold: Wild Type

A

120

Amplitude (dB)

100

Baseline
Temporary Shift
Permanent Shift

80

60

40

20

0
5.0

10.0

20.0

28.3

40.0

Frequency (kHz)

Mean Threshold: M83 Heterozygous

B

120

Amplitude (dB)

100

Baseline
Temporary Shift
Permanent Shift

80

60

40

20

0
5.0

10.0

20.0

28.3

Frequency (kHz)

Mean Threshold: M83 Homozygous

C
140

120

Baseline
Temporary Shift
Permanent Shift

Amplitude (dB)

100

80

60

40

20

0

Frequency (kHz)

36

40.0

Mooney
Figure 4: Mean ABR thresholds by genotype.
This is a bar graph of the mean ABR thresholds for wild-type, M83 heterozygous,
and M83 homozygous mice. On the x-axis is frequency in kHz and the y-axis is ABR
thresholds in dB. The red bar represents the baseline threshold, the green bar represents
the temporary threshold shift, and the blue bar represents the permanent threshold shift.
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Figure 5.
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Figure 5: Gap detection stimulus.
This is a diagram of a stimulus pair. Each stimulus cycle of 150 ms consisted of
two identical wide-band noises (two-octave band width) with nominal rise-fall times of 0
ms. A 5-ms silent period began each cycle. The gap duration (time between the offset of
the first noise and onset of the second noise) varied from 4-32 ms. The full cycle was
repeated every 500 ms.
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Figure 6.
A

B

C

Figure 6: Gap detection noise response.
Section A shows a picture of the waveform of responses for a stimulus pair with a
gap of 16 ms. Section B depicts the waveform showing the ABR to the first noise in the
stimulus pair. Section C displays how the amplitude ratio was calculated.
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Figure 7.
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Figure 7: Gap detection latency shifts for each group.
These are line graphs of the mean latency shifts for each group of mice, plotted as a
function of gap duration. Each panel shows a separate ABR wave. On the x-axis is gap
duration in ms and the y-axis is latency in ms. The solid black line with squares
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represents the wild-type mice, the solid black line with diamonds represents the M83
homozygous mice, and the dotted line represents the M83 heterozygous mice.
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